Table 1.
Area | α-Chain variants | β-Chain variants | α-Thalassemia | β-Thalassemia |
---|---|---|---|---|
Northern Iran | ||||
Gilan | −α 3.7 kb (42.5%) | IVS II-1 G : A (52.4%) | ||
Mazandaran | −α 3.7 kb (44.9%) | IVS II-1 G : A (62.1%) | ||
Golestan | IVS II-1 G : A (33.3%) | |||
Northwestern Iran | ||||
East Azerbaijan and Ardabil | IVS II-1 G : A (21%) | |||
West Azerbaijan | IVS II-1 G : A (35%) | |||
Northeastern Iran | ||||
Khorasan | CD 8/9 +G (62.5%) | |||
Central Iran | ||||
Isfahan | Hb S | IVS II-1 G : A (20.5 and 28%) | ||
Southwestern Iran | ||||
Fars | Hb S | α 3.7 kb (71.7%) | IVS II-1 G : A (24, 31 and 47.8%) | |
Khuzestan | Hb S Hb D-Punjab |
−α 3.7 kb (62.6%) | CD 36/37 –T (20.5%) IVS II-1 G : A (20%) |
|
Western Iran | ||||
Kermanshah |
Hb Q-Iran Hb Setif |
Hb D-Punjab |
IVS II-1 G : A (33%) |
|
Kurdistan | IVS II-1 G : A (35%) | |||
Lorestan | CD 36/37 –T (33.8%) IVS II-1 G : A (27.7%) |
|||
Southern Iran | ||||
Hormozgan | −α 3.7 kb (79.1%) | IVS I-5 G : C (69%) | ||
Southeastern Iran | ||||
Sistan-Balouchestan | IVS I-5 G : C (87.2%) | |||
Kerman | −α 3.7 kb (83.8%) | IVS I-5 G : C (66.2%) | ||
Iranians (with different ethnicity) | −α 3.7 kb (60.2%) | IVS II-1 G : A (34%) |